Day One Biopharma's experimental glioma drug gets an orphan designation in Europe

Retrieved on: 2021-06-21 13:29:40

Tags for this article:

Click the tags to see associated articles and topics

Day One Biopharma's experimental glioma drug gets an orphan designation in Europe. View article details on hiswai:

Excerpt

Shares of Day One Biopharmaceuticals Inc. DAWN, +4.45% gained 9.4% in premarket trading on Monday after the company said its experimental ...

Article found on: www.marketwatch.com